Evaluation of an Innovative Tuberculosis Diagnostic Test
PROMISE-TB
Evaluation, of Innovative Tuberculosis Diagnostic Tests - Promoting Infant Health and Nutrition in Sub-Saharian Africa (PROMISE Consortium)
1 other identifier
observational
300
1 country
1
Brief Summary
Diagnosis of tuberculosis (TB)in young children is a challenge due to atypical non-specific symptoms, difficulty to expectorate mucus, paucibacillary nature of pulmonary TB and low sensitivity of available diagnostic tools. This project aims at evaluating two innovative immunological methods for diagnosing of active TB among HIV-infected and uninfected children.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jul 2013
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2013
CompletedFirst Submitted
Initial submission to the registry
September 22, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2015
CompletedFirst Posted
Study publicly available on registry
October 12, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2015
CompletedOctober 12, 2015
October 1, 2015
2.3 years
September 22, 2015
October 9, 2015
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Proportion of children with tuberculosis who are correctly identified by a immunoenzymatic test for tuberculosis as having the condition
baseline
Proportion of tuberculosis negative children who are correctly identified as such by a immunoenzymatic test for tuberculosis
baseline
Study Arms (6)
HIV-infected children with confirmed TB
Hospitalized children with TB confirmed by culture or GeneXpert
HIV-uninfected children aged<5 years with confirmed TB
Hospitalized children aged\<5 years with TB confirmed by culture or GeneXpert
HIV-uninfected children aged>4 years with confirmed TB
Hospitalized children aged\>4 years with TB confirmed by culture or GeneXpert
HIV-infected control children
Children hospitalized in the surgery ward without any evidence of tuberculosis infection
HIV-uninfected controls aged <5 years
Children \<5 years hospitalized in the surgery ward without any evidence of tuberculosis infection
HIV-uninfected controls aged >4 years
Children \>4 years hospitalized in the surgery ward without any evidence of tuberculosis infection
Eligibility Criteria
Children aged 0 to 15 years with a definite diagnosis of tuberculosis infection, HIV-infected or uninfected. They will be matched on age and HIV status, to an equivalent number of children without any evidence of tuberculosis infection.
You may qualify if:
- one of 4 clinical signs
- persistent and unexplained cough
- unexplained weight loss or failure to thrive
- persistent and unexplained fever
- persistent and unexplained lethargy or reduced playfulness
- chest X-Ray consistent with a tuberculosis infection
- an adenitis compatible with non-pulmonary tuberculosis Among these children only those with confirmed TB will be analysed for the primary outcome
- children without any of the signs and symptoms quoted above
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Department of Paediatrics and Child Health, University Teaching Hospital.UNZA-SOM
Lusaka, Zambia
Biospecimen
Urine Serum Cell culture supernatant
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Edouard Tuaillon, MD, PhD
Université de Montpellier, France
- STUDY DIRECTOR
Chipepo Kankasa, MD, PhD
University of Zambia, Zambia
- STUDY CHAIR
Philippe Van de Perre, MD, PhD
Université de Montpellier, France
- PRINCIPAL INVESTIGATOR
Nicolas Nagot, MD, PhD
Université de Montpellier, France
Central Study Contacts
Study Design
- Study Type
- observational
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER GOV
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 22, 2015
First Posted
October 12, 2015
Study Start
July 1, 2013
Primary Completion
October 1, 2015
Study Completion
December 1, 2015
Last Updated
October 12, 2015
Record last verified: 2015-10